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1  | INTRODUC TION
Anesthesia-induced neurodegeneration (AIN) occurs in newborn 
large animal models where physiological homeostasis is main-
tained. However, most immature rodent models of AIN report 
mortality rates, and hypercarbia alone, mimicking that produced 
by anesthesia, increases neuro-apoptosis.1 The potential influence 
of physiological derangement is one reason why rodent models of 
AIN are not ideal for predicting clinical effect. However, they re-
main necessary for the initial pre-clinical investigation of toxicity 
or treatment.
Xenon, a cardio-stable sedative with analgesic properties and 
shown to reduce isoflurane-AIN in an immature rodent model,2 was 
recently administered to critically ill babies in UK research trials 
and was shown to reduce the requirement for sevoflurane during 
anesthesia in another European trial. Co-administration during an-
esthesia for babies and young children potentially offers improved 
hemodynamics and neuroprotection.
We aimed to compare the effect of co-administering Xenon with 
sevoflurane on neuroapoptosis and acid–base homeostasis in imma-
ture rats.
2  | METHOD
These experiments were carried out under Home Office License, 
with University ethical approval. Mixed sex, Wistar rats were ran-
domly assigned on postnatal day 8 to 6-hour exposures to equipo-
tent mixtures of sevoflurane ± xenon in 30% oxygen (equivalent to 
thrice the effective inhaled concentration of sevoflurane or xenon 
preventing cold-stimulated vocalization in 95% [EiC95 CSV]3): 2.7% 
sevoflurane alone (Sevo), 1.8% sevoflurane in 35% xenon (SevoXe35) 
or 0.9% sevoflurane in 70% xenon (SevoXe70) (n = 9 per group). Two 
control groups were used (Naïve: anesthetized and culled on removal 
from the home cage, and Sham: expose to 30% oxygen alone [n = 6 
per group]). Gasses were delivered using calibrated, low flow, rota-
meters and monitoring ensured that CO2 rebreathing was limited 
to 2%. Immediate decapitation allowed collection of mixed arterio-
venous blood for analysis.
Brains were harvested, drop fixed, cryoprotected, and coronal 
blocks were frozen. 25 µm section were cut on a cryostat (Leica 
3050), mounted on slides, and stained for cleaved caspase-3 (CC3) 
immunofluorescence. CC3-positive cells were counted by a re-
searcher blinded to group allocation in four brain areas: Pre-frontal 
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, 
provided the original work is properly cited.
© 2020 The Authors. Pediatric Anesthesia published by John Wiley & Sons Ltd
     |  373GILL et aL.
cortex (comprising Sensory Cortex [S1], Motor cortex [M1] and 
Cingulate Gyrus [Cg]), Caudate Putamen [Cpu], Somatosensory 1 
Barrel Field [S1BF] and hippocampus comprising CornuAmmonis 1 
and 3 [CA1, CA3] and Dentate Gyrus [DG]).
Sample size was calculated using a conservative interpretation 
of data from Ma et al.2 A two-way ANOVA was used to compare 
apoptotic cell count by brain area and control group (Naive or Sham). 
There was no effect of control group (P = .645), therefore, differ-
ences in apoptotic cell count between Control, Sevo, SevoXe35, 
and SevoXe70 were tested using Kruskal–Wallis with Bonferroni 
correction for multiple comparisons. The relationships between 
RR and PCO2, and pH and induced apoptosis were estimated using 
Spearman's Rank correlation coefficient (values between 0.4 and 
0.59, 0.6 and 0.79 or 0.8 and 1.0 indicate moderate, strong or very 
strong correlation).
3  | RESULTS
No animals died during the six-hour exposures. The results are 
shown in the Figure 1. Sevoflurane induced severe acidosis and sig-
nificant apoptosis in the Sensory Cortex, Pre-frontal Cortex, and 
Hippocampus. Co-administration of Xenon, reducing the exposure 
to sevoflurane, significantly lessened the acidosis in a dose-depend-
ent manner and, at the higher Xenon concentration (70%), prevented 
induced apoptosis.
Lactate remained normal in our animals suggesting severe cir-
culatory failure was not present, and the pH we report is in keeping 
with a recent study showing induced apoptosis in rats exposed to six 
hours of 2.5% sevoflurane (mean arterial blood pH: 7.04).4
The relationships between RR and PCO2, and pH and induced 
apoptosis were estimated using Spearman's Rank correlation co-
efficient. There was a very strong negative correlation between 
respiratory rate and pCO2 of mixed arterio-venous blood (−0.99, 
P < .001). There was less acidosis with increased xenon/decreased 
sevoflurane (P < .001). Lactate was not raised in any animal 
(<3 mmol/L), and there was no difference between the three groups 
(P = .282).
There was a moderate negative correlation between pH and 
apoptotic cell count in the sensory cortex (−0.50, P = .028), but not 
in the hippocampus or the pre-frontal cortex (P = .092 and P = .342, 
respectively).
4  | CONCLUSIONS
Our study shows that xenon-co-administration in neonatal rats, 
used to reduce sevoflurane exposure, lessened physiological 
disturbances and this was accompanied by reduced apoptosis 
in the brain. Further pre-clinical studies are needed where car-
diorespiratory derangement is minimized and equal between 
groups.
F I G U R E  1   Median (IQR) apoptotic cell count in four brain areas according to treatment group (Panels, A-D): There were few apoptotic 
cells in any control animals (<8/mm2)(A-D). Compared to controls, there were more apoptotic cells in the Hippocampus, Sensory Barrel 
Cortex and Pre-frontal Cortex in the Sevo and SevoXe35 groups, but not SevoXe70 (B-D). In the Hippocampus there were fewer apoptotic 
cells in SevoXe70 compared to Sevo group (B). In contrast, in the Caudate Putamen there were very few apoptotic cells seen and no 
difference between groups (A). Differences were tested using Kruskall-Wallis (P value above each panel) with Bonferroni correction for 
multiple comparisons (bracketed P values within panels). Median (IQR) Respiratory rate, PCO2 and pH of mixed arterio-venous blood 
taken immediately after 6-hour exposures (right sided panels): All animals exposed to sevoflurane alone or combined with xenon had lower 
respiratory rates compared to sham animals and were acidotic (pH < 7.35) [Colour figure can be viewed at wileyonlinelibrary.com]
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